Sanjeev Suratwala, MD
Orthopaedic Surgery of the Spine · Great Neck, NYNPI 1447296355
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,658 of the $3,680 with a category attached, or 72.2%. Medtronic accounts for 69.1% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2023 at $2,622 and has fallen 95.6% since, to $115 in 2024. That places this record below the midpoint for orthopaedic surgery of the spine clinicians in NY, where the typical reported total is $11,594.
Across 27 payments — averaging $136.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Zimmer Biomet$632
- Zimvie Inc.$335
- Seaspine Orthopedics Corporation$172
What the payments were for
- Travel & lodging$2,65872%
- Food & beverage$1,02228%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 17 | $2,541 |
| Zimmer Biomet | 5 | $632 |
| Zimvie Inc. | 4 | $335 |
| Seaspine Orthopedics Corporation | 1 | $172 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CD HORIZON SPINAL SYSTEM$2,019
- Mobi-C$670
- Mariner$172
- MAZOR X SYSTEM$153
- SOVEREIGN SPINAL SYSTEM$102
How this compares
$3,680 in reported general payments places this provider in the 30th percentile of 161 orthopaedic surgery of the spine providers in New York.
See all orthopaedic surgery of the spine providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 20 | $1,297 |
| Gabapentin | 233 | $997 |
| Tizanidine Hcl | 185 | $725 |
| Diclofenac Sodium-MisoprostolDiclofenac Sodium/Misoprostol | 14 | $624 |
| Celecoxib | 20 | $597 |
| Diclofenac Sodium | 113 | $543 |
| Methylprednisolone | 43 | $278 |
| Baclofen | 49 | $237 |
| Meloxicam | 54 | $137 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Great Neck
- Hansen YuanSyracuse$31.7M
- Frank SchwabNew York$5.1M
- Han KimNew York$3.9M
- Todd AlbertNew York$2.7M
- Jeffrey SpivakNew York$1.3M
- Aaron BucklandNew York$1M
- Seth NeubardtWhite Plains$902K
- Sheeraz QureshiNew York$828K
- Jeffrey GoldsteinNew York$765K
- Fabien BitanNew York$624K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.